Learning Objectives

Not only is the use of OTC medications, in general, is increasing, but many more OTC versions of formerly prescription-only medications becoming readily available. It is vital to understand the potential influences of these drugs on human fertility.

Our course experts for this course are Dr. Kathleen Tucker and Dr. Angie Beltsos. Dr. Tucker has been working as Lab/Scientific Director in human IVF laboratories for almost 30 years, and she was the Scientific Director for one of the largest programs in The Netherlands, where her interest in the effects of OTC medications on semen and oocytes first began. She currently acts as an advisor for Eggschain, and she has a consulting business, K.E. Tucker Consulting.

Dr. Angeline N. Beltsos, is the CEO and Chief Medical Officer of Vios Fertility Institute. She is board certified in Obstetrics and Gynecology and in Reproductive Endocrinology and Infertility (REI) and has been practicing since 1991.

Intended Audience:

This course is designed for infertility patients, infertility nurses and nurse practitioners, as well as other professionals working in the field of infertility or women’s health.

Participants will be able to:

  1. Describe the impact of OTC medicines on fertility: male and female.
  2. Describe the impact of OTC medicines when taken during  fertility treatment.
  3. Explain the impact of OTC medicines on pregnancy.
  4. Understand the impact of other OTC products that may impact fertility.

Impact of OTC Medicines on Fertility OUTLINE

Nurse/Nurse Practitioner Continuing Education Information: 

1.25 Hour CE credit by NPWH (estimated time to complete course 1 h 15 m)

NPWH Approval Period: 7/21/2021 - 7/21/2023

* A certificate of completion will be immediately awarded online upon successful completion of the course including passing a 10-question quiz (with a score of 80% or higher) and completing a course evaluation. 

Accreditations and Approvals: This activity has been evaluated and approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women's Health for 1.25 contact hours, including 0 contact hours of pharmacology. NPWH Activity number 21-11. Each participant should claim only those contact hours that he/she actually spent in the educational activity.

Disclosure for Planners & Content Development_Impact of OTC Medication on Fertility.pdf

*Course Date: 3/2021.  All content presented herein has been collected and presented with the best knowledge and intent possible at the time of recording.

Your course will remain active for 90 days from purchase date.